mpox, World Health Organization

World Health Organization approves emergency use of second mpox vaccine
The World Health Organization Tuesday granted emergency use authorization for the second mpox vaccine. The LC16m8 vaccine from Japan's KM Biologics is the second since WHO declared mpox a health emergency in August.
Mpox still a health emergency, says WHO
The Mpox outbreak continues to represent a public health emergency, the World Health Organization said on Friday. The WHO first declared the emergency in August, when an outbreak of a new form of mpox spread from the badly-hit Democratic Republic of Congo to neighbouring countries.
WHO extends public health emergency for mpox
Following a meeting today of the World Health Organization (WHO) mpox emergency committee, the head of the WHO accepted the group’s recommendation that the outbreaks still warrant a public health emergency of international concern (PHEIC) under the International Health Regulations.
WHO says mpox continues to remain a public health emergency
The Mpox outbreak continues to represent a public health emergency, the World Health Organization said on Friday, November 22, 2024. The WHO first declared the emergency in August, when an outbreak of a new form of mpox spread from the badly-hit Democratic Republic of Congo to neighbouring countries.
WHO lists mpox vaccine by Japan's KM Biologics for emergency use
The World Health Organization listed KM Biologics' mpox vaccine for emergency use on Tuesday, making it the second shot to get the approval of the global health agency. It declared mpox a global public health emergency for the second time in two years in August after a new variant of the virus,
WHO Approves Second Mpox Vaccine
The World Health Organization on Tuesday approved an mpox vaccine from Japanese pharma company KM Biologics for emergency use, the second one to get the agency's seal of approval.
Health Matters: WHO approves first mpox vaccine for kids
The World Health Organization has authorized the first m-pox vaccine for children. It's a decision experts hope will help make immunizations more widely available to one of the hardest-hit populations during the ongoing outbreaks of the disease in Congo and elsewhere in Africa.
First mpox vaccine for children approved by WHO to fight virus outbreak
The vaccine is the second to be approved by the UN agency and the first approved for children aged one and older. View on euronews
Jay Bhattacharya, Born In Kolkata, Emerges As Trump's Top Pick To Head US Health Agency
Jay Bhattacharya, a Stanford University-trained physician and economist, has reportedly emerged as the presumptive favourite ...
Trump fills out his key public health roles
President-elect Donald Trump on Friday announced his picks for critical remaining public health roles in his incoming ...
Eating less sugar would be great for the planet as well as our health
A limited 20% reduction in sugar is estimated to save US$10.3 billion (£8.1 billion) of health costs in the US alone. Yet, ...
What are Trump's plans for public health?
As the dust settles on Donald Trump's electoral victory, many experts are concerned about how a second Trump term will affect ...
Vaccines are ‘absolutely critical’ and save six lives a minute, according to World Health Organization
In a report released in April, the U.N.’s World Health Organization said global immunization efforts have saved an estimated ...
Human Cell Atlas hopes to be 'Google Maps' for health research
Scientists from around the world are making headway in compiling a Human Cell Atlas -- a deep dive into the myriad types of ...
Florida health official advises communities to stop adding fluoride to drinking water
Florida's surgeon general, Dr. Joseph Ladapo, cited developmental concerns from higher levels of fluoride than are found in ...
US health officials report 1st case of new form of mpox in a traveler
Health officials say they have confirmed the first U.S. case of a new form of mpox that was first seen in eastern Congo.
‘It’s impossible to breathe’: Life in the world’s most polluted city
Inside Delhi’s first ever clinic dedicated to pollution-related illnesses, Deepak Rajak struggles to catch his breath.